Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - 1 Jan 2005

Sánchez Alvarez J E, Pérez Tamajón L, Hernández D, Alvarez González A, Delgado P, Lorenzo V

Abstract excerpt

UNLABELLED: High levels of homocysteine (tHcy) are frecuent in MHD patients, and recognized as a risk factor for cardiovascular events. Vitamin supplements have been shown to lower serum Hcys, although optimal dose and efficacy is not well defined. Moreover, methylenetetrahydrofolate reductase (MTHFR) gene polymorphism can modulate its prevalence and response to treatment. OBJECTIVE: To evaluate efficacy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetic Nephropathies
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homocysteine

Share to Hyperhomocysteinemia

Share to Kidney Failure, Chronic

Share to Renal Dialysis

Share to Vitamin B 12

Share to Vitamin B 6

Source

Identifiers

PMID: 16053010

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].PMID 16053010Read ↗

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.Semantic proximity Read ↗

Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.Semantic proximity Read ↗

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.Semantic proximity Read ↗

Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.Semantic proximity Read ↗

Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes.Semantic proximity Read ↗

[Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].Semantic proximity Read ↗

Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy.Semantic proximity Read ↗

The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.Semantic proximity Read ↗

[Some aspects of homocysteine metabolism in hemodialysis patients].Semantic proximity Read ↗

Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.Semantic proximity Read ↗

Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.